Breast Cancer
Biological markers or lack thereof are predictive of clinical recurrence
Published in Women's Health Weekly, June 5th, 2003
According to published research from Australia, "The optimal management of ductal carcinoma in situ (DCIS) is controversial, due in part to our poor understanding of its natural history.
"We undertook to identify subgroups of DCIS based on the expression of biomarkers, which were related to the likelihood of clinical recurrence. Biomarker expression of a total of 95 DCIS lesions in a nested case-control study within a population-based cohort with up to 135 mo...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Acute Myocardial Infarction
Does the menstrual cycle affect when heart attacks occur in women? - Endometrial Cancer
Gene mutation in some uterine tumors may signal that cancer runs in family - Breast Cancer
Sentinel lymph node biopsy is accurate for staging - Environmental Toxins
Prenatal exposure to mercury in fish not associated with impaired neurodevelopment - HIV Prevention
Substance-abusing men place wives at high risk - Oncology
Thymidine phosphorylase signals control the angiogenesis of ovarian cancer - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
